2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$16.10+$0.22 (+1.37%)
Price as of Sep 11, 2026 7:55 PM EDT- $5.6BMarket Cap
- 917.95%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$16.10+$0.22 (+1.37%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.88 | ||
Change | -$0.15 (-0.94%) | ||
Open | $16.05 | ||
High | $16.54 | ||
Low | $15.87 | ||
Previous Close | $16.03 | ||
Volume | 2,883,857 | ||
30-Day Average Volume | 3,765,512 | ||
1-Week Change | -1.91% | ||
1-Month Change | -13.27% | ||
1-Year Change | 917.95% | ||
3-Year Change | 492.54% | ||
5-Year Change | -24.45% | ||
Fundamentals | |||
Shares Outstanding | 349.8M | ||
Total Assets | $435.1M | ||
Market Cap | $5.6B | ||
Enterprise Value | $5.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$44.1M | ||
Free Cash Flow | -$27.3M | ||
EBIT | -$44.1M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $244.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -127 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -113 | ||
PEG | -1 | ||
Price/Free Cash Flow | -204 | ||
Price/Operating Cash Flow | -204 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue